Growing Number of Respiratory Disease Further Propels The Asthma and COPD Drugs Market
Published: May 2020
Increasing prevalence of respiratory diseases such as asthma and COPD across the globe further prples the demand of asthma and COPD drugs. As per Centre for Diseases Control and Prevention, about 1 in 13 people in the US have asthma in the US, equal to 25 million people.
Emerging Pipeline Drugs to Offer a Significant Scope for the Global Pancreatic Cancer Drugs Market
Published: May 2020
The global pancreatic cancer drugs market has significant opportunity owing to the emerging drugs in the pipeline for the treatment of pancreatic cancer. Several immunotherapies and targeted therapies are under the pipeline. Immunotherapies are mostly in trial stages and less is available on the market for the treatment of pancreatic cancer.
Strong Pipeline to Provide an Opportunity for the Global Macular Degeneration Treatment Market
Published: May 2020
The global macular degeneration treatment market is estimated to grow at a CAGR of nearly 7.0% during the forecast period. Due to the increasing geriatric population and the rising incidences of age-related macular degeneration (AMD), the pharmaceutical companies are working towards reinforcing their pipeline products for AMD treatment.
Significant demand for chemotherapy to reflect positively on the Global Cytotoxic Drugs Market
Published: May 2020
The global cytotoxic drugs market is estimated to grow at a CAGR of nearly 1.3% during the forecast period. Significant rise in cancer incidences has led the demand for chemotherapy which utilizes specialized medications to reach and kill cancer cells in a part of the body, rather than surgery and radiation, which target particular areas.
Increasing Presence of Technologies Such as Artificial Intelligence (AI), Big Data and IoT to propel Collective Intelligence Platform Market
Published: May 2020
The collective intelligence platform market is projected to grow at a significant CAGR during the forecast period (2019-2025). The collective intelligence (CI) or group intelligence refers to the intellect that comes through the collection, collaboration, collective efforts, and competition of many individuals. The collective intelligence platform has its utility in consensus decision making.
Emerging Demand for Topical and Inhaled Corticosteroids is Driving The Global Corticosteroids Market
Published: May 2020
The global corticosteroids market is estimated to grow at a CAGR of nearly 4.8% during the forecast period. Rising demand for topical and inhaled corticosteroids is primarily encouraging the growth of the market.
Emerging Applications and Technological Innovations to Reflect Positively on The Global Bionics Market
Published: May 2020
The global bionics market is estimated to grow at a CAGR of nearly 9.0% during the forecast period. Technological innovations have been reflecting the shifting preference towards bionics products. Several innovations are reported in the field of bionics for healthcare, defense, and industrial applications.
Covid-19 Will Provide Exponential Growth to the Preventive Vaccine Market
Published: May 2020
The global preventive vaccine market is estimated to grow at a CAGR of nearly 9.0% during the forecast period. Before the COVID-19, the major dynamic moving the market include rising per capita healthcare expenditure of the emerging economies, and increasing awareness related to the vaccine.
Few Companies Ruling the Pediatric Vaccine Market
Published: May 2020
The global pediatric vaccine market is expected to grow at a CAGR of over 9% during the forecast period. Major players operating in the pediatric vaccine market include Sanofi SA, GlaxoSmithKline PLC, CSL Ltd., Merck & Co., Inc., and Pfizer Inc. It is a consolidated market and a large share of the overall market is hold by these few players.
Biosimilars Will Shrink the Market of Adalimumab
Published: May 2020
The adalimumab market is expected to witness a negative CAGR during the forecast period 2020-2026. Adalimumab is a biological drug sold by AbbVie Inc., under the brand name Humira for the treatment of various diseases including arthritis, Crohn's disease, ulcerative colitis, and others.